These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7875198)

  • 21. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
    Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
    Koide J; Rivas A; Engleman EG
    J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.
    Ferrini S; Cambiaggi A; Cantoni C; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
    Int J Cancer Suppl; 1992; 7():15-8. PubMed ID: 1428398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytes.
    Ferrini S; Prigione I; Bottino C; Ciccone E; Tambussi G; Mammoliti S; Moretta L; Moretta A
    Eur J Immunol; 1989 Jan; 19(1):57-61. PubMed ID: 2784109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery.
    Moretta A; Bottino C; Tripodi G; Vitale M; Pende D; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Millo R
    Int J Cancer Suppl; 1992; 7():6-10. PubMed ID: 1428407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
    Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
    J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The regulatory role of CD45 on rat NK cells in target cell lysis.
    Giezeman-Smits KM; Gorter A; van Vlierberghe RL; v Eendenburg JD; Eggermont AM; Fleuren GJ; Kuppen PJ
    J Immunol; 1999 Jul; 163(1):71-6. PubMed ID: 10384101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets.
    Ramos OF; Patarroyo M; Yefenof E; Klein E
    J Immunol; 1989 Jun; 142(11):4100-4. PubMed ID: 2565929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.
    Pérez-Villar JJ; Melero I; Rodríguez A; Carretero M; Aramburu J; Sivori S; Orengo AM; Moretta A; López-Botet M
    J Immunol; 1995 Jun; 154(11):5779-88. PubMed ID: 7751628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
    Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
    J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.
    Jones RA; Richards SJ; Patel D; Scott CS
    Immunology; 1991 Jul; 73(3):342-7. PubMed ID: 1831793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
    Uciechowski P; Gessner JE; Schindler R; Schmidt RE
    Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
    J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
    Moretta A; Tambussi G; Bottino C; Tripodi G; Merli A; Ciccone E; Pantaleo G; Moretta L
    J Exp Med; 1990 Mar; 171(3):695-714. PubMed ID: 2137855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.